Overview

• Construction will begin by the end of 2024, with operations expected to start in 2029.
• The plant will produce antibody-drug conjugates (ADCs) that target cancer cells while sparing healthy ones.
• This investment is supported by Singapore's Economic Development Board.
• The facility is designed to have zero carbon emissions from its first day of operation.
• AstraZeneca aims to enhance its supply chain and reduce reliance on China.